Molecular Diagnostics (Biocartis / Wondfo) Overview
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Molecular Diagnostics (Biocartis / Wondfo) General Information
Description
A joint venture incorporated to commercialize the fully automated molecular diagnostics platform in mainland China.
Contact Information
Corporate Office
- China
Corporate Office
- China
Molecular Diagnostics (Biocartis / Wondfo) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Molecular Diagnostics (Biocartis / Wondfo) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Molecular Diagnostics (Biocartis / Wondfo) FAQs
-
Where is Molecular Diagnostics (Biocartis / Wondfo) headquartered?
Molecular Diagnostics (Biocartis / Wondfo) is headquartered in China.
-
What industry is Molecular Diagnostics (Biocartis / Wondfo) in?
Molecular Diagnostics (Biocartis / Wondfo)’s primary industry is Diagnostic Equipment.
-
Is Molecular Diagnostics (Biocartis / Wondfo) a private or public company?
Molecular Diagnostics (Biocartis / Wondfo) is a Private company.
-
What is Molecular Diagnostics (Biocartis / Wondfo)’s current revenue?
The current revenue for Molecular Diagnostics (Biocartis / Wondfo) is .
-
Who are Molecular Diagnostics (Biocartis / Wondfo)’s investors?
Biocartis Group and Guangzhou Wondfo Biotech have invested in Molecular Diagnostics (Biocartis / Wondfo).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process